＊ Network with top executives, investors, experts and renown leaders from Taiwan, China, and beyond
＊ Exhibit bioclusters, technologies, unique products and services
＊ Discover biopharma innovations in Taiwan and Asia
＊ Capture Greater China and Asia's biotech market opportunities through Taiwan
＊ Explore R&D, products, services and new partnerships
Taiwan's biotech industry market value has reached 900bil TWD (30bil USD) and will soon approach its first trillion TWD as Taiwan becomes an integral part of the global biopharma industry chain. The government's initiatives to support Taiwan's biotech development and innovation are critical for continued strong growth momentum. BioBuisness Asia explores such investment opportunities in Taiwan. The event takes an in-depth look at issues regarding bio-investing and future trends in biomedical and life sciences within the Asia region. In 2017, the BioTaiwan exhibition had a record number of participants, reaching a total of 600 exhibitors, 1,310 booths, and 95,168 plus visitors mostly from China, Hong Kong, Korea and Japan; following is Australia and a few from Europe. This year the event also attracted new visitors from ASEAN countries, including Indonesia, Thailand, Malaysia, Singapore, Philippine, and Vietnam.